Search results
Freeze-Dried Mare Colostrum Easier To Store, May Be As Effective As Frozen
Paulick Report· 20 hours agoColostrum, the first milk produced by mares and other mammals, is incredibly important to giving a...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 13 hours agoRemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88 PR Newswire YANTAI, China, June ...
... Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of...
KOIN News 6 Portland· 2 days ago...biopharmaceutical company that develops, manufactures and commercializes high-quality medicines...
...Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with...
KOIN News 6 Portland· 2 days ago...that develops, manufactures and commercializes high-quality medicines for the treatment of...
... Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
Benzinga· 2 days agoEvorpacept in combination with PADCEV®, an approved antibody-drug conjugate ("ADC"), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with Samuel A. Funt,
Leonard Schleifer
Fortune· 5 hours agoRegeneron is a research-oriented biotech, founded by Schleifer, that had no product on the market for its first 20 years. Today its monoclonal antibodies, particularly Eylea for retinal diseases ...
Novel vaccine concept generates immune responses that could produce multiple types of HIV...
Medical Xpress· 5 days agoUsing a combination of cutting-edge immunologic technologies, researchers have successfully...
Antibodies may aid effort to fight influenza B: st | Newswise
Newswise· 4 days agoResearchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately affects children ...
Vaccination induces broadly neutralizing antibody precursors to HIV gp41 - Nature Immunology
Nature· 5 days agoSchief and colleagues show that germline-targeting epitope scaffolds can elicit responses from rare broadly neutralizing antibody precursor B cells with predefined binding specificities and genetic features.
ASCO24: Akeso’s bispecific vvonescimab faces a rocky road ahead in NSCLC
Pharmaceutical Technology via Yahoo Finance· 3 days agoCompared...
